Citations

Showing 10 of 108094 citations.

Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma
Bhindi, Bimal , Habermann, Elizabeth B. , Mason, Ross , Costello, Brian A. , Pagliaro, Lance C. , Thompson, R. Houston, Leibovich, Bradley C. , Boorjian, Stephen A. , Habermann, Elizabeth

Mayo Clinic

Journal of Urology | March 21, 2018 | Volume: 200 | Issue: 3 | Pages: 528-534

10.1016/j.juro.2018.03.077 | PMID 29574109 Get It

Serum Triamcinolone Levels following Cervical Interlaminar Epidural Injection
Lamer, Tim J. , Dickson, Rozalin R. , Gazelka, Halena M. , Nicholson, Wayne T. , Moeschler, Susan M. , Hooten, W. Michael , Reid, Joel M. , Hooten, W Michael , Lamer, Tim J

Mayo Clinic

Pain Research and Management | March 21, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-5

10.1155/2018/8474127 | PMID 29755622 Get It

Background. Cervical interlaminar epidural steroid injections (ESIs) are commonly performed procedures to treat painful cervical radiculopathy, but little is known about the systemic absorption and serum levels of steroids following injection. The primary objective of this study was to investigate the pharmacokinetics of fluoroscopy-guided cervical epidural-administered triamcinolone acetonide in a cohort of patients with cervical radicular pain seeking treatment in a pain medicine clinic.Methods. The study cohort included eight patients undergoing a fluoroscopically guided C7-T1 interlaminar ESI at a pain medicine specialty clinic. Blood was collected prior to the ESI and on days 1, 2, 4, 6, 8, 14, 21, 28, 35, and 42 following the injection. The sample extract was analyzed by tandem mass spectrometry.Results. The terminal elimination half-life of cervical epidural-administered triamcinolone in a noncompartmental analysis was 219 hours. In the noncompartmental analysis, peak triamcinolone concentrations of 5.4 ng/mL were detected within 22.1 hours after administration.Conclusions. The pharmacokinetics of cervical epidural-administered triamcinolone is consistent with our previous study of lumbar ESI, demonstrating that the elimination half-life is longer than that which has been reported following intravenous triamcinolone. The elimination half-life was shorter following cervical ESI than that which has been reported following lumbar ESI.
Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)
Phipps, Amanda I. , Shi, Qian , Dotan, Efrat , Goldberg, Richard M. , Hardikar, Sheetal , Jahagirdar, Balkrishna, Shields, Anthony F. , Zemla, Tyler J, Limburg, Paul J. , Shi, Qian , Zemla, Tyler , Gill, Sharlene , Newcomb, Polly A. , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 21, 2018 | Volume: 27 | Issue: 6 | Pages: 696-703

10.1158/1055-9965.epi-17-0769 | PMID 29563133 Get It

AbstractBackground: Prior studies have supported an inverse association between physical activity and colon cancer risk and suggest that higher physical activity may also improve cancer survival. Among participants in a phase III adjuvant trial for stage III colon cancer, we assessed the association of physical activity around the time of cancer diagnosis with subsequent outcomes.Methods: Before treatment arm randomization (FOLFOX or FOLFOX + cetuximab), study participants completed a questionnaire including items regarding usual daily activity level and frequency of participation in recreational physical activity (N = 1,992). Using multivariable Cox models, we calculated HRs for associations of aspects of physical activity with disease-free (DFS) and overall survival (OS).Results: Over follow-up, 505 participants died and 541 experienced a recurrence. Overall, 75% of participants reported recreational physical activity at least several times a month; for participants who reported physical activity at least that often (vs. once a month or less), the HRs for DFS and OS were 0.82 [95% confidence interval (CI), 0.69–0.99] and 0.76 (95% CI, 0.63–0.93), respectively. There was no evidence of material effect modification in these associations by patient or tumor attributes, except that physical activity was more strongly inversely associated with OS in patients with stage T3 versus T4 tumors (Pinteraction = 0.03).Conclusions: These findings suggest that higher physical activity around the time of colon cancer diagnosis may be associated with more favorable colon cancer outcomes.Impact: Our findings support further research on whether colon cancer survival may be enhanced by physical activity. Cancer Epidemiol Biomarkers Prev; 27(6); 696–703. ©2018 AACR.
Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices
Brown, Caitlin S. , Zemrak, Wesley R. , Dyer, Kaitlin, Rolfe, Stephen

Mayo Clinic

ASAIO Journal | March 21, 2018 | Volume: 65 | Issue: 2 | Pages: e21-e24

10.1097/mat.0000000000000783 | PMID 29561270 Get It

Left ventricular assist devices (LVADs) have become an important advancement for patients with end-stage heart failure. Left ventricular assist devices come with the risk of stroke and pump thrombosis, and to mitigate these risks, anticoagulation is given to these patients. With anticoagulation comes increased bleeding risk, and urgent reversal may be necessary. Reports have shown that the risk of thrombosis with prothrombin complex concentrate (PCC) does exist, especially in patients with baseline risk factors for thrombosis. We describe two cases of warfarin reversal with low-dose 4-factor PCC (4F-PCC) in two different LVAD patient scenarios. Low-dose 4F-PCC was administered to one patient with a Heart Mate II (HM II) LVAD, international normalized ratio (INR) of 4.7 on admission and in need of an urgent procedure. He received approximately 16 units/kg of 4F-PCC with reversal of his INR to 2.3 within 45 minutes. The second patient also had a HM II LVAD and presented with a right occipital intraparenchymal hemorrhage and subdural hematoma with an INR of 3.7. He received approximately 11 units/kg of 4F-PCC with INR reversal to 1.6 within 1 hour. Both of these patients had no thrombotic complications and successful reversal of their INR with low-dose 4F-PCC. Further investigation into low-dose 4F-PCC dosing strategies is warranted.
Identifying Barriers to Preemptive Kidney Transplantation in a Living Donor Transplant Cohort
Helmick, Ryan A. , Jay, Colleen L. , Price, Brittany A., Dean, Patrick G. , Stegall, Mark D. , Stegall, Mark D

Mayo Clinic

Transplantation Direct | March 21, 2018 | Volume: 4 | Issue: 4 | Pages: e356

10.1097/txd.0000000000000773 | PMID 29707627 Get It

Background Despite substantial evidence demonstrating clear benefit, rates of preemptive kidney transplantation (PreKTx) remain low in the United States. Our goal was to identify barriers to PreKTx. Methods Using a telephone-administered questionnaire including questions about barriers, timing of referral, timing of education, we retrospectively studied first living donor kidney transplant recipients (2006-2010) at Mayo Clinic, Rochester, MN. Of 235 patients, 145 (62%) responded to the questionnaire (74 PreKTx and 71 non-PreKTx). We compared categorical data with Fisher exact test and median times with Wilcoxon rank sum test. Results Polycystic kidney disease (PCKD), longer median time between diagnosis and transplant, and time between education about transplant and transplant correlated with PreKTx (P < 0.01). The presence of at least 1 patient-identified barrier (lack of referral, financial barriers, medical barriers, no identified living donor and donor evaluation delays) was associated with non-PreKTx (0.034) though no single barrier predominated. Age, education level, insurance status and source of referral (primary care, nephrology, and nonphysician referral) were not associated with the rate of PreKTx. Univariate logistic regression identified white race, PCKD, and increased time from diagnosis as factors favoring PreKTx; PCKD and increased time remained significant factors after multivariate analysis. Conclusions Even among a patient population that is primarily white, educated, and has a spouse or first-degree relative donor, PreKTx rates remain concerningly low. Increased time between diagnosis or education and transplant are predictors of PreKTx. Greater emphasis on transplant education earlier in the stages of chronic kidney disease and community outreach from transplant centers may help to increase the rate of PreKTx.
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
Waldman, Scott A. , Camilleri, Michael , Waldman, Scott A

Mayo Clinic

Gut | March 21, 2018 | Volume: 67 | Issue: 8 | Pages: 1543-1552

10.1136/gutjnl-2018-316029 | PMID 29563144 Get It

Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent disorders of the GI tract and consume a significant proportion of healthcare resources. Recent studies have shown that membrane-bound guanylate cyclase-C (GC-C) receptors lining the GI tract may serve as novel therapeutic targets in the treatment of FGIDs and IBDs. GC-C receptor activation by its endogenous paracrine hormones uroguanylin and guanylin, and the resulting intracellular production of its downstream effector cyclic GMP, occurs in a pH-dependent manner and modulates key physiological functions. These include fluid and electrolyte homeostasis, maintenance of the intestinal barrier, anti-inflammatory activity and regulation of epithelial regeneration. Studies of the GC-C paracrine signalling axis have revealed the therapeutic potential of these receptors in treating GI disorders, including chronic idiopathic constipation and irritable bowel syndrome–constipation. This review focuses on the evolving understanding of GC-C function in health and disease, and strategies for translating these principles into new treatments for FGIDs and IBDs.
Vascular Malformations and Health-Related Quality of Life
Nguyen, Henry, Bonadurer, George F., Tollefson, Megha M. , Nguyen, Henry L

Mayo Clinic

JAMA Dermatology | March 21, 2018 | Volume: 154 | Issue: 6 | Pages: 661

10.1001/jamadermatol.2018.0002 | PMID 29562060 Get It

TRPC6 and TRPC4 Heteromultimerization Mediates Store Depletion-Activated NCX1 Reversal in Proliferative Vascular Smooth Muscle Cells
Liu, Bei , Roos, Carolyn M, Prakash, Y. S. , Miller, Jordan D. , Guo, Rui-wei, Prakash, Y S , Zhang, Bin , Liu, Bei, Thompson, Michael A. , Miller, Jordan

Mayo Clinic

Channels | March 21, 2018 | Volume: 12 | Issue: 1 | Pages: 119-125

10.1080/19336950.2018.1451696 | PMID 29560783 Get It

What’s New in Hand and Wrist Surgery
Kakar, Sanjeev , Kakar, Sanjeev

Mayo Clinic

Journal of Bone and Joint Surgery | March 21, 2018 | Volume: 100 | Issue: 6 | Pages: 526-532

10.2106/jbjs.17.01404 | PMID 29557870 Get It

Effect of Postoperative Mechanical Axis Alignment on Survival and Functional Outcomes of Modern Total Knee Arthroplasties with Cement
Abdel, Matthew P. , Ollivier, Matthieu , Parratte, Sébastien , Trousdale, Robert T. , Berry, Daniel J. , Pagnano, Mark W. , Abdel, Matthew P , Berry, Daniel J

Mayo Clinic

Journal of Bone and Joint Surgery | March 21, 2018 | Volume: 100 | Issue: 6 | Pages: 472-478

10.2106/jbjs.16.01587 | PMID 29557863 Get It

Abstract: We previously compared the 15-year survivorship of total knee arthroplasty (TKA) implants that were mechanically aligned (0° ± 3° relative to the mechanical axis) compared with those that were outside that range and considered outliers. The original publication included 398 TKAs (292 in the aligned group and 106 in the outlier group) performed from 1985 to 1990. At the time of follow-up in the previous study, 138 patients (155 TKAs) had died and 59 knees had been revised. Since that publication, 49 additional patients (87 knees) have died. At 20 years, 57 (19.5%) of the 292 knees in the mechanically aligned group had been revised compared with 16 (15.1%) of the 106 knees in the outlier group (p = 0.97). Postoperative alignment within 0° ± 3° of the mechanical axis did not provide a functional advantage at 1, 5, 10, 15, and/or 20 years postoperatively as demonstrated by the Knee Society scores being similar between the groups (p ≥ 0.2 at all intervals). At 20 years, we once again did not find that neutral mechanical alignment provided better implant survivorship than that found in the outlier group. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.